Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 3
2001 3
2002 5
2003 6
2004 1
2005 3
2006 2
2007 4
2008 1
2009 1
2010 6
2011 4
2012 3
2013 3
2014 3
2015 3
2016 4
2017 1
2019 2
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial.
Di Giacomo AM, Covre A, Finotello F, Rieder D, Danielli R, Sigalotti L, Giannarelli D, Petitprez F, Lacroix L, Valente M, Cutaia O, Fazio C, Amato G, Lazzeri A, Monterisi S, Miracco C, Coral S, Anichini A, Bock C, Nemc A, Oganesian A, Lowder J, Azab M, Fridman WH, Sautès-Fridman C, Trajanoski Z, Maio M. Di Giacomo AM, et al. Among authors: sigalotti l. Clin Cancer Res. 2019 Dec 15;25(24):7351-7362. doi: 10.1158/1078-0432.CCR-19-1335. Epub 2019 Sep 17. Clin Cancer Res. 2019. PMID: 31530631 Free article. Clinical Trial.
Epigenetic immunomodulation of hematopoietic malignancies.
Gattei V, Fonsatti E, Sigalotti L, Degan M, Di Giacomo AM, Altomonte M, Calabrò L, Maio M. Gattei V, et al. Among authors: sigalotti l. Semin Oncol. 2005 Oct;32(5):503-10. doi: 10.1053/j.seminoncol.2005.07.006. Semin Oncol. 2005. PMID: 16210091 Review.
Epigenetic markers of prognosis in melanoma.
Sigalotti L, Fratta E, Parisi G, Coral S, Maio M. Sigalotti L, et al. Methods Mol Biol. 2014;1102:481-99. doi: 10.1007/978-1-62703-727-3_25. Methods Mol Biol. 2014. PMID: 24258994
60 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page